loadpatents
name:-0.025409936904907
name:-0.0056681632995605
name:-0.00042915344238281
Koo; Ja Seong Patent Filings

Koo; Ja Seong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koo; Ja Seong.The latest application filed is for "bosentan controlled release oral preparation".

Company Profile
0.8.27
  • Koo; Ja Seong - Deajeon KR
  • Koo; Ja-Seong - Daejeon KR
  • Koo; Ja Seong - Daejon KR
  • Koo; Ja Seong - Yuseong-gu KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bosentan Controlled Release Oral Preparation
App 20140377346 - Kim; Sung Wuk ;   et al.
2014-12-25
Pharmaceutical Composition Having Activity Of Anticancer
App 20140235558 - Kim; Sung-Wuk ;   et al.
2014-08-21
Anti-cancer Pharmaceutical Composition
App 20140235559 - Kim; Sung-Wuk ;   et al.
2014-08-21
Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
Grant 8,642,083 - Kim , et al. February 4, 2
2014-02-04
N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,541,474 - Kim , et al. September 24, 2
2013-09-24
Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity
App 20130158084 - KIM; Sung Wuk ;   et al.
2013-06-20
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
Grant 8,394,845 - Kim , et al. March 12, 2
2013-03-12
Butyric Acid Salt Of N,n-dimethyl Imidocarbon Imidic Diamide, Method Of Preparing Same, And Pharmaceutical Compositions And Combinations Containing Same
App 20120135952 - Kim; Sung Wuk ;   et al.
2012-05-31
Combination Preparation Comprising Inhibitor Of Hmg-coa Reductase And Aspirin And Method For Manufacturing The Same
App 20120015032 - Kim; Sung Wuk ;   et al.
2012-01-19
N, N -dimethyl Imidodicarbonimidic Diamide Acetate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20120010287 - KIM; Sung Wuk ;   et al.
2012-01-12
N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,076,377 - Kim , et al. December 13, 2
2011-12-13
N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,058,312 - Kim , et al. November 15, 2
2011-11-15
Combination Preparation Comprising Angiotensin-ii-receptor Blocker And Hmg-coa Reductase Inhibitor
App 20110212175 - Kim; Sung Wuk ;   et al.
2011-09-01
Method Of Using Combination Preparation Comprising Angiotensin-ii-receptor Blocker And Hmg-coa Reductase Inhibitor
App 20110213004 - Kim; Sung Wuk ;   et al.
2011-09-01
Pharmaceutical Preparation Containing Non-dihydropyridine Calcium Channel Blocker And Angiotensin-2 Receptor Blocker
App 20110123612 - Kim; Sung Wuk ;   et al.
2011-05-26
Pharmaceutical Formulation Containing Angiotensin-ii Receptor Blocker
App 20110117194 - Kim; Sung Wuk ;   et al.
2011-05-19
Pharmaceutical Preparation
App 20110111021 - Kim; Sung Wuk ;   et al.
2011-05-12
Pharmaceutical Formulation
App 20110111022 - Kim; Sung Wuk ;   et al.
2011-05-12
Pharmaceutical Preparation For Treating Cardiovascular Disease
App 20110052683 - Kim; Sung Wuk ;   et al.
2011-03-03
Composite Preparation
App 20110038931 - Kim; Sung Wuk ;   et al.
2011-02-17
Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
App 20100272797 - Kim; Sung Wuk ;   et al.
2010-10-28
N,n-dimethyl Imidodicarbonimidic Diamide Dicarboxylate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20100249241 - KIM; Sung Wuk ;   et al.
2010-09-30
Controlled Release Pharmaceutical Composition Containing Thiazides And Angiotensin-ii-receptor Blockers
App 20100143470 - Kim; Sung Wuk ;   et al.
2010-06-10
N, N -dimethyl Imidodicarbonimidic Diamide Acetate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20100087544 - Kim; Sung Wuk ;   et al.
2010-04-08
Controlled Release Complex Composition Comprising Angiotensin-ii-receptor Blockers And Hmg-coa Reductase Inhibitors
App 20100074951 - Kim; Sung Wuk ;   et al.
2010-03-25
Combined Preparation For The Treatment Of Cardiovascular Diseases Based On Chronotherapy Theory
App 20100047341 - Kim; Sung Wuk ;   et al.
2010-02-25
Combined Pharmaceutical Formulation With Controlled-release Comprising Dihydropyridine Calcium Channel Blockers And Hmg-coa Reductase Inhibitors
App 20080241240 - Kim; Sung Wuk ;   et al.
2008-10-02
Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
App 20080050432 - Jun; Sung Soo ;   et al.
2008-02-28
Pharmaceutical Compositions And Formulations Of Metformin Extended Release Tablets
App 20070275061 - Jo; Young Gwan ;   et al.
2007-11-29
Metformin Tablet with Sustained Release and Method for Preparing the Same
App 20070042042 - Jo; Young Gwan ;   et al.
2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed